Covered recipient · General Payments record
STEPHANIE J SHEPHERD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,123.78
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $683.75 | 28 |
| Education | $90.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $276.34 | 6 |
| ABBVIE INC. | $247.49 | 12 |
| Amgen Inc. | $169.19 | 7 |
| Insulet Corporation | $29.88 | 1 |
| Lilly USA, LLC | $17.27 | 1 |
| Novo Nordisk AS | $17.16 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.19 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187373 | CMS |
| ABBVIE INC. | $122.29 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187375 | CMS |
| ABBVIE INC. | $8.26 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187377 | CMS |
| ABBVIE INC. | $9.41 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187379 | CMS |
| ABBVIE INC. | $9.23 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187381 | CMS |
| ABBVIE INC. | $9.41 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187383 | CMS |
| ABBVIE INC. | $16.43 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187385 | CMS |
| ABBVIE INC. | $6.60 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187387 | CMS |
| ABBVIE INC. | $12.08 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187389 | CMS |
| ABBVIE INC. | $8.83 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187391 | CMS |
| ABBVIE INC. | $9.38 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187393 | CMS |
| ABBVIE INC. | $9.38 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108187395 | CMS |
| Amgen Inc. | $7.23 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117682534 | CMS |
| Amgen Inc. | $101.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117682538 | CMS |
| Amgen Inc. | $9.88 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117381428 | CMS |
| Amgen Inc. | $10.59 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117381430 | CMS |
| Amgen Inc. | $10.59 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117682536 | CMS |
| Amgen Inc. | $17.90 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117381432 | CMS |
| Amgen Inc. | $11.16 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117682540 | CMS |
| Astellas Pharma US Inc | $11.62 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139477578 | CMS |
| Astellas Pharma US Inc | $18.47 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139480644 | CMS |
| Astellas Pharma US Inc | $125.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139524330 | CMS |
| Astellas Pharma US Inc | $90.00 | 04/16/2024 | Education | Undisputed | 01/23/2026 | 1139506383 | CMS |
| Astellas Pharma US Inc | $14.71 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139542410 | CMS |
| Astellas Pharma US Inc | $16.54 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139557377 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.42 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086339827 | CMS |
| Insulet Corporation | $29.88 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116821732 | CMS |
| Lilly USA, LLC | $17.27 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135891774 | CMS |
| Novo Nordisk Inc | $17.16 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100507281 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.